Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
A recent study published in Lancet Neurology reveals important associations between MSH3 gene mutations and Huntington’s disease progression and disease burden.
There is a new study that suggests there may be an easy way to diagnose Parkinson’s Disease from other similar diseases early on. This method relies on measuring…
A new drug called Austedo, has been approved by the FDA for the treatment of involuntary movements associated with chorea. Austedo is a small molecule drug designed to…
Each month we present you with the latest featured study from the research teams at JAMA, Journal of the American Medical Association. Check out the video for intriguing…
A man signed up for treatment of his Parkinson’s Disease, but the therapy wasn’t medicine, it was cycling. In fact, researchers at the Cleveland Clinic have found that…
Dr. Robert Chen of the Institute of Medical Science at the University of Toronto, discusses the need for the study of brain plasticity in patients with movement disorders.…
An overflow of movement called Dyskinesia can impair someone’s quality of life. The movements can be fluid and dance like, jerking or slow, and extended muscle spasms. These…
